BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 34691064)

  • 41. Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    J Rheumatol; 2017 Jul; 44(7):996-1003. PubMed ID: 28412707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
    Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
    Kessel C; Vollenberg R; Masjosthusmann K; Hinze C; Wittkowski H; Debaugnies F; Nagant C; Corazza F; Vély F; Kaplanski G; Girard-Guyonvarc'h C; Gabay C; Schmidt H; Foell D; Tepasse PR
    Arthritis Rheumatol; 2021 Oct; 73(10):1791-1799. PubMed ID: 33880885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
    Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience.
    Lian F; Wang Y; Yang X; Xu H; Liang L
    Rheumatol Int; 2012 Jan; 32(1):189-92. PubMed ID: 20798946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrophage activation syndrome in neonates born to mothers with adult-onset Still's disease: Perinatal effect of maternal IL-18.
    Shimizu M; Kizawa T; Kato R; Suzuki T; Yachie A
    Clin Immunol; 2019 Oct; 207():36-39. PubMed ID: 31299380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.
    Wakabayashi K; Inokuma S; Matsubara E; Onishi K; Asashima H; Nakachi S; Hagiwara K
    Clin Rheumatol; 2013 Jul; 32(7):999-1005. PubMed ID: 23504210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
    Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
    J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
    Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
    Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refractory macrophage activation syndrome in the setting of adult-onset Still disease with hemophagocytic lymphohistiocytosis detected on skin biopsy treated with canakinumab and tacrolimus.
    Chamseddin B; Marks E; Dominguez A; Wysocki C; Vandergriff T
    J Cutan Pathol; 2019 Jul; 46(7):528-531. PubMed ID: 30927277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis.
    Félix FH; Leal LK; Fontenele JB
    Rheumatol Int; 2009 Jun; 29(8):973-4. PubMed ID: 19115058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
    Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
    J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
    Naymagon L; Tremblay D; Troy K; Mascarenhas J
    Eur J Haematol; 2020 Sep; 105(3):255-261. PubMed ID: 32353917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical manifestations of Adult-onset Still's disease presenting with erosive arthritis: Association with low levels of ferritin and Interleukin-18.
    Ichida H; Kawaguchi Y; Sugiura T; Takagi K; Katsumata Y; Gono T; Ota Y; Kataoka S; Kawasumi H; Yamanaka H
    Arthritis Care Res (Hoboken); 2014 Apr; 66(4):642-6. PubMed ID: 24124073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia.
    Kirino Y; Takeno M; Iwasaki M; Ueda A; Ohno S; Shirai A; Kanamori H; Tanaka K; Ishigatsubo Y
    Arthritis Res Ther; 2005; 7(3):R616-24. PubMed ID: 15899048
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.